Cargando…
Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia
BACKGROUND: Adult T-cell leukemia/lymphoma (ATL) is an aggressive malignancy of CD4(+)CD25(+) lymphocytes caused by human T-cell lymphotropic virus type 1. While much progress has been made in understanding the mechanisms of cellular dysregulation, the prognosis for aggressive ATL still remains poor...
Autores principales: | Ju, Wei, Zhang, Meili, Petrus, Michael, Maeda, Michiyuki, Pise-Masison, Cynthia A, Waldmann, Thomas A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060757/ https://www.ncbi.nlm.nih.gov/pubmed/24890041 http://dx.doi.org/10.1186/1742-4690-11-43 |
Ejemplares similares
-
Augmented efficacy with the combination of blockade of the NOTCH-1 pathway, Bortezomib and Romidepsin in a murine MT-1 adult T cell leukemia model
por: Yu, Ping, et al.
Publicado: (2014) -
Reproductive toxicology. 9-Aminoacridine hydrochloride.
Publicado: (1997) -
9-aminoacridine Inhibition of HIV-1 Tat Dependent Transcription
por: Guendel, Irene, et al.
Publicado: (2009) -
Kinetics of 9-aminoacridine block of single Na channels
Publicado: (1984) -
The evolving role of alemtuzumab (Campath-1H) in renal transplantation
por: Pham, Phuong-Thu T, et al.
Publicado: (2009)